R&D Systems™ Recombinant Human OX40/TNFRSF4 His-tag Protein

Catalog No.	Quantity
99-69O-X050	50 μg

Catalog No. 99-69O-X050 Supplier R&D Systems™ Supplier No. 9969OX050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Human OX40/TNFRSF4 is coated at 0.25 μg/mL (100 μL/well), the concentration of Recombinant Human OX40 Ligand/TNFSF4 (Catalog # 1054-OX ) that produces 50% optimal binding response is 0.25-1.5 ng/mL.

Specifications

• Accession Number: P43489
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 7293
• Molecular Weight (g/mol): M.W. (Observed): 40-44 kDa, reducing conditions; M.W. (theoretical): 21 kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human OX40/TNFRSF4 protein Leu29-Ala216, with a C-terminal 6-His tag
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: OX40/TNFRSF4
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: OX40/TNFRSF4